Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of SINOVAC BIOTECH LTD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
SINOVAC BIOTECH LTD quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2018 to Q4 2023.
  • SINOVAC BIOTECH LTD Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2023 was $6.22M, a 32.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

SINOVAC BIOTECH LTD Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.22M -$2.97M -32.3% 31 Dec 2023 20-F 29 Apr 2024
Q4 2022 $9.19M -$8.43M -47.8% 31 Dec 2022 20-F 01 May 2023
Q4 2021 $17.6M +$6.74M +61.8% 31 Dec 2021 20-F 29 Apr 2022
Q4 2020 $10.9M +$10.1M +1307% 31 Dec 2020 20-F 22 Apr 2021
Q4 2019 $774K -$36K -4.44% 31 Dec 2019 20-F 30 Apr 2020
Q4 2018 $810K 31 Dec 2018 20-F 29 Apr 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.